All News

During a 15-year period, 1 in 5 older adults living with COPD received a shingles vaccine.

Pelabresib is an investigational, oral, small molecule that inhibits bromodomain and extraterminal (BET) proteins.

Fabry disease is a rare lysosomal disorder that causes excessive deposition of lipids in tissues.

The data support the use of supportive anemia care agents in combination with ruxolitinib (Jakafi; Incyte Corp).

The authors suggest that targeted interventions to mitigate financial toxicity should be implemented to better support patients.

Zenocutuzumab-zbco is a bispecific antibody that targets and binds to HER2 and HER3.

The treatment is a type IA prodrug of dexamethasone that targets CD206+ macrophages.

The indication is for adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not progressed after platinum-based chemotherapy and radiation therapy.

Prevalence increased across all subgroups among children and adolescents, with decreases observed in young adults and elderly populations.

Sacituzumab tirumotecan (sac-TMT; Kelun Pharmaceutical, Merck) is currently being studied to treat non-small cell lung cancer (NSCLC) in the TroFuse-004 and TroFuse-009 trials.

The American Society of Hematology (ASH) Annual Meeting and Exposition will include the latest news and clinical trial updates in the hematology field.

The decline was attributed to continued adherence to infection prevention and control measures.

Examining challenges in pharmacy school is necessary to solve current problems in the workforce.

Metabolic bariatric surgery rates has decreased in response to increased use of glucagon-like peptide-1 (GLP-1) receptor agonists.

Anemia is a very common adverse effect associated with the use of ruxolitinib.

Key trends shaping the future of health-system pharmacy include advanced medication management to address supply chain challenges, digital transformation to enhance pharmacy operations, and strategies for compliance with evolving regulations, all of which will be central topics at the ASHP Midyear 2024 meeting.

Clinicians' enthusiasm for cell and gene therapies is tempered by practical concerns.

These risks were observed to become higher as gestational age decreased.

The study also found that HSSPs minimize health costs and provide additional revenue for health systems.

Advocacy ensures that policymakers understand the realities on the ground. If we fail to speak up, decisions about our profession will be made without our input—often by individuals who lack the expertise and perspective we bring to the table.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses a study she conducted that highlights how social determinants of health exacerbate severity and increase rates of mortality from Clostridioides difficile infections in vulnerable communities.

High-dose vitamin C, when combined with chemotherapy, has shown the potential to double the survival rate of patients with late-stage metastatic pancreatic cancer.

A vast majority of patients achieved a positive clinical response with the combination, with improvements in their ocular condition.

Investigators say basic immunodeficiency screening should be completed in full for this patient population.

Postural orthostatic tachycardia syndrome (POTS) diagnoses have greatly increased following the COVID-19 pandemic.

E-cigarette manufacturers claim the products aid in smoking cessation for adults without the risk of adolescent usage.

The therapy has similar benefits for both older and younger patients with multiple myeloma.

The authors recommend that longer assessments with lengthier interventions should be performed to assess potential benefits.